| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021240 |
| Receipt No. | R000024350 |
| Official scientific title of the study | Exploratory performance comparison trial of titanium allergy diagnostic agent |
| Date of disclosure of the study information | 2016/03/01 |
| Last modified on | 2019/01/28 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Exploratory performance comparison trial of titanium allergy diagnostic agent | |
| Title of the study (Brief title) | Exploratory performance comparison trial of titanium allergy diagnostic agent | |
| Region |
|
|
| Condition | ||||
| Condition | Titanium allergy | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To produce a diagnostic agent for titanium allergy |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Positive rate, negative rate, safety (rate of irritation response) and specificity to 0.1%, 0.5% titanium sulfate solution, 0.1% titanium chloride solution and oxidized titanium on the 7th day. |
| Key secondary outcomes | Expression frequency and rate of adverse events |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Perform patch test to healthy person with titanium sulfate solution and titanimu chloride solution and oxidized titanium, it is judged according to the criteria of International Contact Dermatitis Research Group(ICDRG) on the second, third and seventh day. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Subjects who agree to participate for a week-long study.
2.Subjects who agree for a written informed consent for participating in this study. 3. Subjects without any symptoms of allergy (allergic dermatitis, palmoplantar pustulosis and lichen planus) and titanium allergy over the past decade. |
|||
| Key exclusion criteria | 1. Subjects who cannot interrupt the anti-allergic drugs from 3 days before patch test to date ended.
2. Subjects who have used corticosteroid medicine internally and/or externally within 1 month prior to the study. 3. Pregnant women and women of child bearing potential. 4. Subjects who cannot give informed consent. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Hidemi Kurihara |
| Organization | Hiroshima University Hospital |
| Division name | Department of Periodontics and Endodontics |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima |
| TEL | 082-257-5663 |
| hkuri@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Masae Kitagawa |
| Organization | Hiroshima University Hospital |
| Division name | Center of Oral Clinical Examination |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima |
| TEL | 082-257-5727 |
| Homepage URL | |
| mhiraoka@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Hiroshima University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024350 |